These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16698931)
21. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma. Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596 [No Abstract] [Full Text] [Related]
22. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969 [TBL] [Abstract][Full Text] [Related]
23. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692 [TBL] [Abstract][Full Text] [Related]
24. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Migone TS; Zhang J; Luo X; Zhuang L; Chen C; Hu B; Hong JS; Perry JW; Chen SF; Zhou JX; Cho YH; Ullrich S; Kanakaraj P; Carrell J; Boyd E; Olsen HS; Hu G; Pukac L; Liu D; Ni J; Kim S; Gentz R; Feng P; Moore PA; Ruben SM; Wei P Immunity; 2002 Mar; 16(3):479-92. PubMed ID: 11911831 [TBL] [Abstract][Full Text] [Related]
25. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443 [TBL] [Abstract][Full Text] [Related]
26. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030 [TBL] [Abstract][Full Text] [Related]
27. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. Prehn JL; Thomas LS; Landers CJ; Yu QT; Michelsen KS; Targan SR J Immunol; 2007 Apr; 178(7):4033-8. PubMed ID: 17371957 [TBL] [Abstract][Full Text] [Related]
28. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation. Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454 [TBL] [Abstract][Full Text] [Related]
29. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection. Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964 [TBL] [Abstract][Full Text] [Related]
30. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Aiba Y; Nakamura M Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414 [TBL] [Abstract][Full Text] [Related]
31. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Kang YJ; Kim WJ; Bae HU; Kim DI; Park YB; Park JE; Kwon BS; Lee WH Cytokine; 2005 Mar; 29(5):229-35. PubMed ID: 15760679 [TBL] [Abstract][Full Text] [Related]
32. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS Front Immunol; 2019; 10():1624. PubMed ID: 31379829 [TBL] [Abstract][Full Text] [Related]
33. Oestrogen-deficiency induces bone loss by modulating CD14 Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941 [TBL] [Abstract][Full Text] [Related]
34. The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator. Richard AC; Ferdinand JR; Meylan F; Hayes ET; Gabay O; Siegel RM J Leukoc Biol; 2015 Sep; 98(3):333-45. PubMed ID: 26188076 [TBL] [Abstract][Full Text] [Related]
35. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. Cavallini C; Lovato O; Bertolaso A; Pacelli L; Zoratti E; Zanolin E; Krampera M; Zamò A; Tecchio C; Cassatella MA; Pizzolo G; Scupoli MT PLoS One; 2013; 8(4):e60136. PubMed ID: 23565196 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Qin T Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644 [TBL] [Abstract][Full Text] [Related]
38. The TNF family member TL1A induces IL-22 secretion in committed human T Thomas LS; Targan SR; Tsuda M; Yu QT; Salumbides BC; Haritunians T; Mengesha E; McGovern DP; Michelsen KS J Leukoc Biol; 2017 Mar; 101(3):727-737. PubMed ID: 27733581 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis. Meng F; Jiang X; Wang X; Zheng Q; Wang XN; Mei C; Yan S; He Y; Xue J; Zhang X; Fu W; You Y; Zhai J; Wang Y; Sun X Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2120771120. PubMed ID: 37579137 [TBL] [Abstract][Full Text] [Related]
40. Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion. Levin I; Zaretsky M; Aharoni A PLoS One; 2017; 12(3):e0173460. PubMed ID: 28278297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]